Short Squeeze Setup — velZ +10.99 · age 10w×1.00 · 8.83%
Founder-Led — founder/CEO led
About Autolus Therapeutics Ltd
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in the United Kingdom and internationally. The company offers AUCATZYL, a gene therapy product consisting of autologous T cells that are transduced with a lentiviral vector to express a novel anti-CD19 chimeric antigen receptor. Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: June 22, 2018
Headquarters: The Mediaworks, London, United Kingdom, W12 7FP
Founder-Led: Yes — Martin Pule (Founder, Senior Vice President and Chief Scientific Officer)
Key Metrics
Current Price
$1.81
Market Cap
$471M
Float
102.9M
Shares Outstanding
266.2M
Price/Sales (TTM)
4.01
vs. Analyst Target
+382.0% to analyst PT
Profit Margin
-238.65%
Operating Margin (TTM)
-95.95%
Revenue (TTM)
$117M
Dividend Rate
None
Analyst Target Price
$8.72 (9 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$1.7M
-$142M
-$133M
-$163M
2021
$1.5M
-$142M
$1.5M
-$132M
2022
$6.2M
-$149M
$6.2M
-$132M
2023
$1.7M
-$208M
$1.7M
-$157M
2024
$10.1M
-$221M
-$131M
-$233M
2025
$75.6M
-$288M
-$21.0M
-$250M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Sep 2025
$21.2M
-$79.1M
Dec 2025
$24.3M
-$90.2M
Mar 2026
$26.2M
-$71.6M
Jun 2026
$45.7M
-$39.1M
Ownership & Float
Insider Ownership
18.1%
Institutional Ownership
63.4%
Short Float
8.8%
% of All Funds Holding
0.94%
Number of Funds Holding
83
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$2.05
Near-term / short-term trend
Weekly
40-Week SMA
$1.66
Medium-term trend
Weekly
80-Week SMA
$1.68
Cyclical trend (business cycle)
Weekly
200-Week SMA
$2.72
Secular trend (multi-year)
Monthly
10-Month SMA
$1.69
Near-term monthly trend
Monthly
20-Month SMA
$1.72
Medium-term monthly trend
Monthly
40-Month SMA
$2.79
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$1.80
support
1.69x
1 months ago
$3.30
resistance
1.25x
21 months ago
Historical Earnings Reactions (33 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
0.24%
0.00%
48.48%
6.83%
-7.55%
1 Day
-1.64%
-1.20%
48.48%
20.65%
-14.62%
1 Week
-1.21%
0.12%
51.52%
20.98%
-27.30%
2 Weeks
3.42%
3.68%
54.55%
53.13%
-27.15%
1 Month
4.72%
4.29%
56.25%
65.93%
-38.75%
Next earnings: November 11, 2026 (30 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
-14.6%
12.5%
8
Feb
-4.8%
25.0%
8
Mar
-5.0%
37.5%
8
Apr
-4.2%
37.5%
8
May
19.5%
75.0%
8
Jun
-1.9%
50.0%
8
Jul
1.5%
33.3%
9
Aug
6.2%
55.6%
9
Sep
-9.0%
33.3%
9
Oct
1.2%
25.0%
8
Nov
13.5%
50.0%
8
Dec
-3.4%
25.0%
8
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
0.38%
49.7%
392
Tuesday
-0.28%
44.1%
429
Wednesday
0.02%
47.3%
425
Thursday
0.06%
48.1%
418
Friday
-0.13%
43.6%
417
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 63.4%
Insider Transactions — Smart Summary
Total insider ownership: 18.1%
Founder-led management: Martin Pule (Founder, Senior Vice President and Chief Scientific Officer)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Autolus Therapeutics Ltd
(AUTL) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.